Thrombolytic TherapyStreptokinaseTissue Plasminogen ActivatorFibrinolytic AgentsMyocardial InfarctionPlasminogen ActivatorsBrain IschemiaAnistreplaseCerebral InfarctionCerebral HemorrhageStrokeCerebral ArteriesUrokinase-Type Plasminogen ActivatorPulmonary EmbolismTreatment OutcomeTime FactorsHeparinMyocardial ReperfusionCerebral AngiographyCerebrovascular CirculationEmbolectomyThrombosisAcute DiseaseMiddle Cerebral ArteryInfarction, Middle Cerebral ArteryIntracranial ThrombosisCoronary Care UnitsCerebral PalsyFibrinolysisIntracranial Embolism and ThrombosisIntracranial HemorrhagesHemorrhageHeart Rupture, Post-InfarctionElectrocardiographyBrainTomography, X-Ray ComputedProspective StudiesCarotid Artery ThrombosisInfusions, IntravenousAngioplasty, Balloon, CoronaryFibrinolysinRecurrenceCoronary ThrombosisInjections, IntravenousReperfusionCoronary AngiographyEmergency Medical ServicesRecombinant ProteinsVascular PatencyInfusions, Intra-ArterialCerebrovascular DisordersEmergenciesVenous ThrombosisRetrospective StudiesAnticoagulantsIntracranial EmbolismInjections, Intra-ArterialEmergency TreatmentHirudin TherapyCreatine KinaseFollow-Up StudiesMalaria, CerebralEmergency Medical TechniciansRadionuclide VentriculographyThrombectomyHospital MortalityFibrinopeptide AMagnetic Resonance ImagingCerebral VeinsArterial Occlusive DiseasesFibrinogenFibrinEye HemorrhagePatient SelectionRisk FactorsPredictive Value of TestsAngiographyAspirinIschemic Attack, TransientNewfoundland and LabradorRandomized Controlled Trials as TopicInfarction, Anterior Cerebral ArteryCatheterization, PeripheralSurvival AnalysisHeart RuptureStreptodornase and StreptokinasePrognosisDrug Therapy, CombinationBlood CoagulationEcchymosisFibrin Fibrinogen Degradation ProductsHospitals, CommunityCardiac CatheterizationPlasminogenShock, CardiogenicVentricular Septal RuptureMagnetic Resonance AngiographyDisease Models, AnimalSurvival RateRegistries